Neelima Denduluri, M.D.

VCS Physicians

Neelima Denduluri, M.D. Headshot

Primary Location:

Arlington Office

Position

Medical Oncologist

Board Certification

Medical Oncology and Internal Medicine

Fellowship

National Cancer Institute, Medical Oncology

Residency

Georgetown University Medical Center

Medical School

Louisiana State University Medical Center

Dr. Neelima Denduluri earned her medical degree from the Louisiana State University Medical Center, where she served as President of the American Medical Student Association. Upon graduation she received the “Exemplar of Desirable Attitudes of the Physician Towards His Patients” award, which is bestowed upon one graduating senior. She completed her Internal Medicine residency at Georgetown University Medical Center. During her fellowship at the National Cancer Institute, she was honored with the distinction of serving as Chief Fellow. She later served as Assistant Clinical Investigator and Staff Physician at NCI before joining Virginia Cancer Specialists.

Dr. Denduluri remains highly involved in the local community by participating in community outreach, speaking to support groups, and volunteering at the Arlington Free Clinic since 1999. She has consistently been named as a Top Doctor in Northern Virginia Magazine and Washingtonian magazine, and she has been featured in both local and national media for her expertise in breast cancer.

In addition to her passion for patient care, Dr. Denduluri’s dedication to the advancement of medicine has led her to take on multiple leadership roles, including: Associate Chair of the US Oncology Breast Cancer Research Committee; Chair of the American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines Committee; and Cancer Committee Chairman at Virginia Hospital Center. Dr. Denduluri also currently serves as an associate and principal investigator on many clinical trials, and is a steering committee member for NAPBC accreditation for the Reinsch Pierce Family Center for Breast Health.

Dr. Denduluri continues to be active in medical education, currently serving as Clinical Assistant Professor at Georgetown University Medical Center. She has also taught attending students and residents of Virginia Commonwealth University, as well as oncology fellows at the National Navel Medical Center in Bethesda, MD. Dr. Denduluri has published multiple articles and abstracts, and her work has been presented at various national meetings, including the American Society of Clinical Oncology and the San Antonio Breast Cancer Symposium.

Dr. Denduluri is fluent in English, Spanish, and Telugu (an Indian language).


What people are saying…

Physician Publications

December 18, 2017

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Read More
June 7, 2017

Patient Case Lessons: Endocrine Management of Advanced Breast Cancer.

Read More
December 1, 2017

Lifestyle Interventions to Improve Cardiorespiratory Fitness and Reduce Breast Cancer Recurrence.

Read More

More Publications by Neelima Denduluri, M.D.

July 11, 2017

Patient Case Lessons: Endocrine Management of Advanced Breast Cancer

Read More
April 3, 2017

American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations

Read More
February 10, 2017

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.

Read More
February 6, 2017

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.

Read More
February 6, 2017

Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation.

Read More
July 27, 2016

Innovations in American Society of Clinical Oncology Practice Guideline Development.

Read More
July 27, 2016

Selection of Optimal Adjuvant Chemotherapy Regimens for Early Breast Cancer and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline Summary.

Read More
July 27, 2016

Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline.

Read More
November 1, 2015

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

Read More
May 20, 2014

Coginitive Impairments in Older Breast Cancer Patients Prior to Systemic Therapy: Is There an Interaction between Cancer and Comorbidity

Read More
December 1, 2013

Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?

Read More
June 3, 2013

Bridging to Survivorship in Breast Cancer-How BMI Weighs In?

Read More
June 3, 2013

Bridging to survivorship in breast cancer: learning how treatment impacts mental health among early stage breast cancer survivors.

Read More
February 2, 2013

Read More
December 15, 2012

Read More
December 15, 2012

Read More
December 15, 2012

Read More
September 13, 2012

Risk of acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy for early breast cancer in the community setting.

Read More
June 1, 2012

Phase II study of the multikinase inhibitor dovitinib (TKI258) or placebo in combination with fulvestrant in postmenopausal, endocrine resistant HER2-/HR+ breast cancer

Read More
September 8, 2011

Concordance between the 21-gene recurrence score (RS) and the 70-gene profile (MP) in breast cancer (BC) patients (pts)

Read More
June 1, 2011

Ixabepilone: Clinical Role in Metastatic Breast Cancer

Read More
May 1, 2008

Efficacy and cardiac toxicity of trastuzumab combined with pertuzumab in a phase II study in patients with HER2-positive metastatic breast cancer

Read More
March 1, 2008

Ixabepilone for the Treatment of Solid Tumors: A Review of Current Clinical Data

Read More
January 1, 2008

Circulating Biomarkers of Bevacizumab Activity in Patients with Breast Cancer

Read More
August 10, 2007

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients with Metastatic Breast Cancer Previously Untreated with Taxanes

Read More
July 26, 2007

A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer

Read More
January 1, 2007

Are There Downsides Of HER2 Targeted Therapy?: Issues of Cardiotoxicity

Read More
November 27, 2006

Amenorrhea in Premenopausal Women following Adjuvant Chemotherapy for Breast Cancer

Read More
August 25, 2006

Phase II Trial of Ixabepilone, an Epothilone B Analog, Given Daily For Three Days Every Three Weeks, in Metastatic Breast Cancer

Read More
August 1, 2006

Influence of garlic (allium sativum) on the pharmacokinetics of docetaxel

Read More
August 1, 2006

A phase II trial with trastuzumab and pertuzumab in patients with HER2-overexpressed locally advanced and metastatic breast cancer

Read More
February 1, 2006

A phase II trial with trastuzumab and pertuzumab in patients with HER2-overexpressed locally advanced and metastatic breast cancer

Read More
December 1, 2005

A Pilot Study to Evaluate the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor AZD2171 and Chemotherapy in Locally Advanced and Inflammatory Breast Cancer

Read More
August 1, 2005

Serum erythropoietin and aging: a longitudinal analysis

Read More
April 1, 2004

Aging biology and cancer

Read More

Primary Location

Arlington Office Office

Arlington Office

Learn More

Other Locations

Awards

May 23, 2018
Virginia Living Magazine Top Doctor 2018

Top Doctors Virginia Living Magazine 2018


January 1, 2018
Northern Virginia Magazine 2018 Top Doctor

Northern Virginia Magazine Top Doctors 2018


September 9, 2016
Washingtonian Magazine

Top Doctor 2016


September 1, 2015
Washingtonian Magazine

Washingtonian Top Doctor 2015


February 1, 2015
Northern Virginia Magazine

Top Doctor 2015


January 31, 2014
Northern Virginia Magazine

Top Doctor 2014


findme